代谢与减重手术后肥胖相关睡眠呼吸暂停的缓解及其对死亡率和心血管事件的影响:一项倾向匹配队列研究
瑞典全国性登记研究纳入2007至2019年接受袖状胃切除术或Roux-en-Y胃旁路术的患者,比较阻塞性睡眠呼吸暂停(OSA)缓解者与未缓解者及无OSA倾向匹配对照组的结局。中位随访6.8年,74%患者OSA缓解,缓解者10年累积死亡率6.0%对9.1%、主要心血管事件3.4%对5.8%,均显著低于未缓解者,且与基线无OSA对照组相似。
要点
- 代谢减重术后74%的OSA患者达到缓解。
- OSA缓解者10年累积死亡率6.0%,未缓解者9.1%(p<0.001)。
- OSA缓解者10年主要心血管事件累积发生率3.4%,未缓解者5.8%(p<0.001)。
核心结论
- 代谢减重术后OSA缓解率较高,且与未缓解者相比死亡和主要心血管事件风险降低,达到与基线无OSA患者相似的风险水平。
- 作者认为对未达到缓解的患者进行认真随访仍然重要。
研究设计与样本
- 基于登记的全国性研究,纳入2007年至2019年在瑞典接受袖状胃切除术或Roux-en-Y胃旁路术的患者。
- 比较OSA缓解者、未缓解者及倾向评分匹配的无OSA对照组,主要结局为总死亡率,次要结局为主要心血管事件(MACE)。
主要发现
- 共5,892例OSA患者和11,552例匹配的无OSA患者完成1年随访,中位随访6.8年。
- 4,334例患者(74%)达到OSA缓解。
- 术后10年,缓解者累积死亡率6.0%对未缓解者9.1%(p<0.001),MACE累积发生率3.4%对5.8%(p<0.001)。
- 缓解者与基线无OSA对照组相比,死亡率6%对6%(p=0.493)、MACE 3.4%对3.7%(p=0.251),风险相似。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Although obstructive sleep apnea (OSA) is common among patients with obesity and linked to cardiovascular disease, there is a lack of studies evaluating the effects of reaching remission from OSA after metabolic and bariatric surgery. STUDY DESIGN: A registry-based nationwide study including patients operated with sleeve gastrectomy or Roux-en-Y gastric bypass from 2007 until 2019 in Sweden. Patients who reached remission of OSA were compared with those who did not reach remission and a propensity score-matched control group of patients without OSA at the time of operation. The main outcome was overall mortality, and secondary outcome was major cardiovascular events (MACEs). RESULTS: In total, 5,892 patients with OSA and 11,552 matched patients without OSA completed a 1-year follow-up and were followed for a median of 6.8 years. Remission of OSA was seen for 4,334 patients (74%). Patients in remission had a lower risk for overall mortality (cumulative incidence 6.0% vs 9.1%; p < 0.001) and MACE (cumulative incidence 3.4% vs 5.8%; p < 0.001) at 10 years after operation compared with those who did not reach remission. The risk was similar to that of the control group without OSA at baseline (cumulative incidence for mortality 6%, p = 0.493, for MACE 3.7%, p = 0.251). CONCLUSIONS: The remission rate of OSA was high after metabolic and bariatric surgery. This was in turn associated with reduced risk for death and MACE compared with patients who did not achieve remission reaching a similar risk seen among patients without OSA at baseline. A diligent follow-up of patients who do not reach remission remains important.
引用
- Stenberg E, Ottosson J, Näslund E, et al. Remission of Obesity-Related Sleep Apnea and Its Effect on Mortality and Cardiovascular Events after Metabolic and Bariatric Surgery: A Propensity-Matched Cohort Study. J Am Coll Surg. 2024. PMID: 38372341. doi:10.1097/XCS.0000000000001047
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。